US Stock MarketDetailed Quotes

ABBV AbbVie

Watchlist
  • 166.120
  • -3.510-2.07%
Trading Nov 15 10:22 ET
293.56BMarket Cap57.88P/E (TTM)

AbbVie Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AbbVie Q3 2024 Earnings Date

Currency：USDOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
14.28B
14.46B
+183.12M
Beat Est.
+2.51%
+3.83%
+1.28%
EPS
1.44
0.88
-0.56
Miss Est.
+43.60%
-12.00%
-38.72%
Analyst Rating
Buy

Nov 15, 2024

AbbVie Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 13.184B --
-- 2024/Q4 -- / 14.807B --
Oct 30, 2024 2024/Q3 14.460B / 14.277B --
Jul 25, 2024 2024/Q2 14.462B / 14.027B --
Apr 26, 2024 2024/Q1 12.310B / 11.936B --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.184B--
--2024/Q4-- / 14.807B--
Oct 30, 20242024/Q314.460B / 14.277B--
Jul 25, 20242024/Q214.462B / 14.027B--
Apr 26, 20242024/Q112.310B / 11.936B--

Unlock Free Earnings Estimates

AbbVie Earnings Reports

  • AbbVie | 10-Q: Q3 2024 Earnings Report

    Nov 5 03:24

  • AbbVie | 10-Q: Q2 2024 Earnings Report

    Aug 8 03:01

  • AbbVie | 10-Q: Q1 2024 Earnings Report

    May 3 23:06

  • AbbVie | 10-K: FY2023 Annual Report

    Feb 21 01:48

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Buy

    • Buy

      73.68%

    • Hold

      26.32%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data